Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - authors' reply

Steven M Greenberg; Rustam Al-Shahi Salman; Geert Jan Biessels; Mark van Buchem; Charlotte Cordonnier; Jin-Moo Lee; Joan Montaner; Julie A Schneider; Eric E Smith; Meike Vernooij; David J Werring

doi:10.1016/S1474-4422(14)70097-3

Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - authors' reply

Steven M Greenberg, Rustam Al-Shahi Salman, Geert Jan Biessels, Mark van Buchem, Charlotte Cordonnier, Jin-Moo Lee, Joan Montaner, Julie A Schneider, Eric E Smith, Meike Vernooij, David J Werring

Research output: Contribution to journal › Letter

Original language	English
Pages (from-to)	540
Journal	Lancet Neurology
Volume	13
Issue number	6
DOIs	https://doi.org/10.1016/S1474-4422(14)70097-3
Publication status	Published - Jun 2014

Access to Document

10.1016/S1474-4422(14)70097-3

Cerebral Amyloid Angiopathy and intracerebral Haemorrage
Salman, R.
MRC
1/08/11 → 31/01/17
Project: Research

Cite this

Greenberg, S. M., Al-Shahi Salman, R., Biessels, G. J., van Buchem, M., Cordonnier, C., Lee, J.-M., Montaner, J., Schneider, J. A., Smith, E. E., Vernooij, M., & Werring, D. J. (2014). Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - authors' reply. Lancet Neurology, 13(6), 540. https://doi.org/10.1016/S1474-4422(14)70097-3

@article{63e41883679747898ebe806e04963d85,

title = "Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - authors' reply",

author = "Greenberg, {Steven M} and {Al-Shahi Salman}, Rustam and Biessels, {Geert Jan} and {van Buchem}, Mark and Charlotte Cordonnier and Jin-Moo Lee and Joan Montaner and Schneider, {Julie A} and Smith, {Eric E} and Meike Vernooij and Werring, {David J}",

year = "2014",

month = jun,

doi = "10.1016/S1474-4422(14)70097-3",

language = "English",

volume = "13",

pages = "540",

journal = "Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Science",

number = "6",

}

Greenberg, SM, Al-Shahi Salman, R, Biessels, GJ, van Buchem, M, Cordonnier, C, Lee, J-M, Montaner, J, Schneider, JA, Smith, EE, Vernooij, M & Werring, DJ 2014, 'Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - authors' reply', Lancet Neurology, vol. 13, no. 6, pp. 540. https://doi.org/10.1016/S1474-4422(14)70097-3

TY - JOUR

T1 - Developing biomarkers for cerebral amyloid angiopathy trials

T2 - do potential disease phenotypes hold promise? - authors' reply

AU - Greenberg, Steven M

AU - Al-Shahi Salman, Rustam

AU - Biessels, Geert Jan

AU - van Buchem, Mark

AU - Cordonnier, Charlotte

AU - Lee, Jin-Moo

AU - Montaner, Joan

AU - Schneider, Julie A

AU - Smith, Eric E

AU - Vernooij, Meike

AU - Werring, David J

PY - 2014/6

Y1 - 2014/6

U2 - 10.1016/S1474-4422(14)70097-3

DO - 10.1016/S1474-4422(14)70097-3

M3 - Letter

C2 - 24849857

SN - 1474-4422

VL - 13

SP - 540

JO - Lancet Neurology

JF - Lancet Neurology

IS - 6

ER -

Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - authors' reply

Access to Document

Projects

Cerebral Amyloid Angiopathy and intracerebral Haemorrage

Cite this